Targeting reverse tetracycline-dependent transactivator to murine mammary epithelial cells that express the progesterone receptor

Genesis (United States)

Volumn 45, Issue 10, 2007, Pages 639-646

  Mukherjee, Atish ^a   Soyal, Selma M ^b   Fernandez Valdivia, Rodrigo ^a   DeMayo, Francesco J ^a   Lydon, John P ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Krankenhaus Hallein   (Austria)

Author keywords

Progesterone receptor; Reverse tetracycline dependent transactivator, knockin, mouse, mammary gland

Indexed keywords

PROGESTERONE RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F4; TRANSCRIPTION FACTOR REVERSE TETRACYCLINE DEPENDENT; UNCLASSIFIED DRUG;

ARTICLE; BREAST EPITHELIUM; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; IMMUNOHISTOCHEMISTRY; MORPHOGENESIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANIMALIA; MURINAE; MUS;

EID: 36048988717     PISSN: 1526954X     EISSN: 1526968X     Source Type: Journal    
DOI: 10.1002/dvg.20336     Document Type: Article

References (23)

1. Brisken C, Heineman A, Chavarria T, Elenbaas B, Tan J, Dey SK, McMahon JA, McMahon AP, Weinberg RA. 2000. Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev 14:650-654.
2. Brisken C, Park S, Vass T, Lydon JP, O'Malley BW, Weinberg RA. 1998. A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc Natl Acad Sci USA 95:5076-5081.
3. Chatterton RT Jr, Lydon JP, Mehta RG, Mateo ET, Pletz A, Jordan VC. 2002. Role of the progesterone receptor (PR) in susceptibility of mouse mammary gland to 7,12-dimethylbenz[a]anthracene-induced hormone-independent preneoplastic lesions in vitro. Cancer Lett 188:47-52.
4. Clarke RB, Howell A, Potten CS, Anderson E. 1997. Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res 57:4987-4991.
5. D'Cruz CM, Gunther EJ, Boxer RB, Hartman JL, Sintasath L, Moody SE, Cox JD, Ha SI, Belka GK, Golant A, Cardiff RD, Chodosh LA. 2001. c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nat Med 7:235-239.
6. Fata JE, Kong YY, Li J, Sasaki T, Irie-Sasaki J, Moorehead RA, Elliott R, Scully S, Voura EB, Lacey DL, Boyle WJ, Khokha R, Penninger JM. 2000. The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell 103:41-50.
7. Gunther EJ, Belka GK, Wertheim GB, Wang J, Hartman JL, Boxer RB, Chodosh LA. 2002. A novel doxycycline-inducible system for the transgenic analysis of mammary gland biology. FASEB J 16:283-292.
8. Ismail PM, DeMayo FJ, Amato P, Lydon JP. 2004. Progesterone induction of calcitonin expression in the murine mammary gland. J Endocrinol 180:287-295.
9. Ismail PM, Li J, DeMayo FJ, O'Malley BW, Lydon JP. 2002. A novel lacZ reporter mouse reveals complex regulation of the progesterone receptor promoter during mammary gland development. Mol Endocrinol 16:2475-2489.
10. Lee K, Jeong J, Kwak I, Yu CT, Lanske B, Soegiarto DW, Toftgard R, Tsai MJ, Tsai S, Lydon JP, DeMayo FJ. 2006. Indian hedgehog is a major mediator of progesterone signaling in the mouse uterus. Nat Genet 38:1204-1209.
11. Ludwig A, Schlierf B, Schardt A, Nave KA, Wegner M. 2004. Sox10-rtTA mouse line for tetracycline-inducible expression of transgenes in neural crest cells and oligodendrocytes. Genesis 40:171-175.
12. Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery CA Jr, Shyamala G, Conneely OM, O'Malley BW. 1995. Mice lacking progesterone receptors exhibit pleiotropic reproductive abnormalities. Genes Dev 9:2266-2278.
13. Lydon JP, Ge G, Kittrell FS, Medina D, O'Malley BW. 1999. Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function. Cancer Res 59:4276-4284.
14. Medina D, Kittrell FS, Shepard A, Contreras A, Rosen JM, Lydon J. 2003. Hormone dependence in premalignant mammary progression. Cancer Res 63:1067-1072.
15. Mukherjee A, Soyal SM, Fernandez-Valdivia R, Gehin M, Chambon P, DeMayo FJ, Lydon JP, O'Malley BW. 2006a. Steroid receptor coactivator 2 is critical for progesterone-dependent uterine function and mammary morphogenesis in the mouse. Mol Cell Biol 26:6571-6583.
16. Mukherjee A, Soyal SM, Wheeler DA, Fernandez-Valdivia R, Nguyen J, DeMayo FJ, Lydon JP. 2006b. Targeting iCre expression to murine progesterone receptor cell-lineages using bacterial artificial chromosome transgenesis. Genesis 44:601-610.
17. Mulac-Jericevic B, Lydon JP, DeMayo FJ, Conneely OM. 2003. Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. Proc Natl Acad Sci USA 100:9744-9749.
18. Russo J, Ao X, Grill C, Russo IH. 1999. Pattern of distribution of cells positive for estrogen receptor-a and progesterone receptor in relation to proliferating cells in the mammary gland. Breast Cancer Res Treat 53:217-227.
19. Seagroves TN, Lydon JP, Hovey RC, Vonderhaar BK, Rosen JM. 2000. C/EBPb(CCAAT/Enhancer Binding Protein) controls cell fate determination during mammary gland development. Mol Endocrinol 14:359-368.
20. Soyal SM, Mukherjee A, Lee KY, Li J, Li H, DeMayo FJ, Lydon JP. 2005. Cre-mediated recombination in cell lineages that express the progesterone receptor. Genesis 41:58-66.
21. Tibbetts TA, Mendoza-Meneses M, O'Malley BW, Conneely OM. 1998. Mutual and intercompartmental regulation of estrogen receptor and progesterone receptor expression in the mouse uterus. Biol Reprod 59:1143-1152.
22. Urlinger S, Baron U, Thellmann M, Hasan MT, Bujard H, Hillen W. 2000. Exploring the sequence space for tetracycline-dependent transcriptional activators: Novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci USA 97:7963-7968.
23. Yu TS, Dandekar M, Monteggia LM, Parada LF, Kernie SG. 2005. Temporally regulated expression of Cre recombinase in neural stem cells. Genesis 41:147-153.